By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
India Times NowIndia Times NowIndia Times Now
Notification Show More
Font ResizerAa
  • India News
    India News
    Politics is the art of looking for trouble, finding it everywhere, diagnosing it incorrectly and applying the wrong remedies.
    Show More
    Top News
    The States Braces for Protests Over New COVID Rules
    August 29, 2021
    A.P. Chambers draws GST Council’s attention to issues that need redressal
    October 21, 2025
    Yunus keen to improve ties with India, says adviser
    December 24, 2025
    Latest News
    Mamata appears before Calcutta High Court to argue Bengal post-poll violence case
    May 14, 2026
    BRICS Foreign Ministers’ summit: Conflict in West Asia merits particular attention, says Jaishankar
    May 14, 2026
    Panchamasali seer appears before police for questioning in POCSO case in Karnataka
    May 14, 2026
    Thoothukudi will see highest Tasmac closures of liquor shops near schools, places of worship
    May 14, 2026
  • Technology
    TechnologyShow More
    Strengthening the Team: Thryve PR Onboards Pranjal Patil as PR Executive & Project Manager
    October 1, 2025
    How to Take the Perfect Instagram Selfie: Dos & Don’ts
    October 1, 2021
    Apple iMac M1 Review: the All-In-One for Almost Everyone
    Hands-On With the iPhone 13, Pro, Max, and Mini
    September 4, 2021
    Apple VS Samsung– Can a Good Smartwatch Save Your Life?
    August 30, 2021
  • Posts
    • Post Layouts
      • Standard 1
      • Standard 2
      • Standard 3
      • Standard 4
      • Standard 5
      • Standard 6
      • Standard 7
      • Standard 8
      • No Featured
    • Gallery Layouts
      • Layout 1
      • Layout 2
      • layout 3
    • Video Layouts
      • Layout 1
      • Layout 2
      • Layout 3
      • Layout 4
    • Audio Layouts
      • Layout 1
      • Layout 2
      • Layout 3
      • Layout 4
    • Post Sidebar
      • Right Sidebar
      • Left Sidebar
      • No Sidebar
    • Review
      • Stars
      • Scores
      • User Rating
    • Content Features
      • Inline Mailchimp
      • Highlight Shares
      • Print Post
      • Inline Related
      • Source/Via Tag
      • Reading Indicator
      • Content Size Resizer
    • Break Page Selection
    • Table of Contents
      • Full Width
      • Left Side
    • Reaction Post
  • Pages
    • Blog Index
    • Contact US
    • Search Page
    • 404 Page
    • Customize Interests
    • My Bookmarks
  • Join Us
Reading: Q3 results: Pharma stock in focus as revenue increases 45% YoY, check share price
Share
India Times NowIndia Times Now
Font ResizerAa
  • Finance ₹
  • India News
  • The Escapist
  • Entertainment
  • Science
  • Technology
  • Insider
Search
  • Home
    • India Times Now
    • Home 2
    • Home 3
    • Home 4
    • Home 5
  • Categories
    • Technology
    • Entertainment
    • The Escapist
    • Insider
    • Finance ₹
    • India News
    • Science
    • Health
  • Bookmarks
    • Customize Interests
    • My Bookmarks
  • More Foxiz
    • Blog Index
    • Sitemap
Have an existing account? Sign In
Follow US

Home » Q3 results: Pharma stock in focus as revenue increases 45% YoY, check share price

BusinessStartup

Q3 results: Pharma stock in focus as revenue increases 45% YoY, check share price

Times Desk
Last updated: January 29, 2026 8:18 am
Times Desk
Published: January 29, 2026
Share
SHARE


The stock’s 14-day relative strength index (RSI) is 30.63. For the uninitiated, a level above 70 is considered overbought or overvalued, and below 30 is defined as oversold or undervalued.

Mumbai:

Shares of pharma company Sudarshan Pharma Industries Ltd are in focus as the company has reported a 16 per cent increase in net sales to Rs 168.01 crore and a 51 per cent surge in net profit to Rs 4.36 crore for the third quarter of fiscal year 2026. Following this, the stock started the trading session in green at Rs 20.25 against the previous close of Rs 19.30 on the BSE. However, the stock slipped amid profit booking and market volatility and touched the low of Rs 18.50, its 52-week low. The 52-week high of the stock is Rs 43.14, hit on January 29, 2025. Last seen, the stock was trading at Rs 18.53, and the market cap of the company stood at Rs 445.94 crore. 

The stock is trading lower than the 5-day, 20-day, 50-day, 100-day and 200-day moving averages. 

The stock’s 14-day relative strength index (RSI) is 30.63. For the uninitiated, a level above 70 is considered overbought or overvalued, and below 30 is defined as oversold or undervalued.

According to BSE Analytics, the stock has delivered a return of 150.41 per cent in two years, but has corrected 57.05 per cent in one year.

Company forms subsidiary

In the quarter ending December 31, 2025, the company approved the formation of a wholly-owned subsidiary – Sudarshan Pharma Poland Limited Liability Company. Also, the board of directors of the company gave its consent to raise funds of up to Rs 1,500 crore by issuing Foreign Currency Convertible Bonds (FCCB). The company has also submitted its application with the BSE to obtain in-principle approval for the issue of FCCB up to the amount of USD 3,50,00,000.

Share market today

Meanwhile, benchmark equity indices Sensex and Nifty declined in early trade on Thursday after a two-day rally as investors turned cautious ahead of the Union Budget presentation on Sunday.

The 30-share BSE Sensex dropped 343.67 points to 82,001.01 during initial trade. The 50-share NSE Nifty edged lower by 94.2 points to 25,248.55.

ALSO READ | Forgot money in your old bank account? Here’s how you can claim it back in few minutes

(This article is for informational purposes only and should not be construed as investment, financial, or other advice.)





Source link

Shadowfax Technologies IPO listing on NSE, BSE: Stock lists at discount of 9%, check details
Bank Holiday: When will banks be closed for Holi in your city? Check RBI calendar
Market Opening Bell: Sensex falls 67 points, Nifty at 25,410, Adani Ports jumps over 2%
Defence stock gains as company’s subsidiary signs contract worth Rs 1,500 crore, check details
Luana Lopes Lara: From ballerina to world’s youngest self-made woman billionaire at the age of 29
TAGGED:bseCheckfocusincreasesnsepharmaPricequarterly resultsresultsrevenuesharestockstock in focusSudarshan PharmaSudarshan Pharma share priceYoY
Share This Article
Facebook Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe
TelegramFollow

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
[mc4wp_form]
Popular News

No permission required to sail through Strait of Hormuz, says govt official

Times Desk
Times Desk
March 24, 2026
Book ‘Sanatana Sanghi’ lawyer for ‘attack’ on CJI: Thirumavalavan
Bring back J&K resident’s son deported to Pakistan, Jammu and Kashmir High Court tells Home Ministry
Market Opening Bell: Sensex falls 350 points, Nifty below 25,700 amid weak global cues after spike in oil price
Tusker captured in Hassan, sent to Dubare camp
- Advertisement -
Ad imageAd image
Global Coronavirus Cases

Confirmed

0

Death

0

More Information:Covid-19 Statistics
© INDIA TIMES NOW 2026 . All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?